107622-63-9

Upstream product

• 645-00-1 m-iodonitrobenzene 
• 5633-98-7 potassium guaiacolate 
• 585-79-5 m-nitrobromobenzene 
• 860735-45-1 4-(2-methoxy-phenoxy)-2-nitro-aniline 
• 32795-85-0 2-methoxyphenyl 4'-nitrophenyl ether 
• 13066-01-8 4-(2-methoxyphenoxy)-aniline 
• 860577-99-7 N-(4-(2-methoxyphenoxy)phenyl)acetamide 
• 860577-97-5 acetic acid-[4-(2-methoxy-phenoxy)-2-nitro-anilide] 
• 402-67-5 3-fluoro-1-nitrobenzene 
• 90-05-1 2-methoxy-phenol 
• 100-00-5 4-chlorobenzonitrile 

Downstream Products

• 101992-66-9 6-bromo-2-(2-methoxyphenoxy)benzene 
• 116866-54-7 2-(3-Amino-phenoxy)-phenol 
• 860556-64-5 4-bromo-1-methoxy-2-(3-nitro-phenoxy)-benzene 
• 860603-37-8 4-chloro-1-methoxy-2-(3-nitro-phenoxy)-benzene 
• 116289-62-4 3-(2-methoxy-phenoxy)-aniline 

Relevant academic research and scientific papers

PYRIMIDINE AND QUINOLINE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS

The present invention is directed to compounds which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutama

Potentiators of glutamate receptors

The present invention relates to potentiators of metabotropic glutamate receptor function and specifically provides compounds of formula I, compositions thereof and methods of using the same.